Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
Cancers|August 12, 2023
Topographical and Chronological Analysis of Thin Cutaneous Melanoma's Progressions: A Multicentric StudyEmmanouil Chousakos, Daniela Zugna, Emi Dika, et al.
Cells|February 25, 2025
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell LymphomasLiyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv, et al.
Annals of Surgical Oncology|October 26, 2017
Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) StudyCarlo Riccardo Rossi, Simone Mocellin, Luca Giovanni Campana, et al.
Dermatology (Basel, Switzerland)|January 5, 2017
Unknown Primary Melanoma: Worldwide Survey on Clinical ManagementSimone Ribero, Riccardo Pampena, Veronique Bataille, et al.
Cornea|July 5, 2023
Ocular Surface Disease in Patients With Atopic Dermatitis Treated With Dupilumab: A Prospective Case-Control StudyPaola Marolo, Simone Ribero, Paolo Caselgrandi, et al.
Pathologica|November 17, 2025
A novel germline <i>NF1</i> splicing variant drives the onset of an anorectal mucosal melanoma in a patient with a stable and durable nivolumab responseEnrico Berrino, Sara Erika Bellomo, Luca Mastorino, et al.
Expert Opinion on Biological Therapy|July 17, 2023
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life studyLuca Mastorino, Lorenza Burzi, Giada Frigatti, et al.
Diagnostics (Basel, Switzerland)|December 11, 2025
Toward Personalized Response Monitoring in Melanoma Patients Treated with Immunotherapy and Target TherapyFederico Venturi, Elisabetta Magnaterra, Alberto Gualandi, et al.
The Journal of Dermatological Treatment|September 3, 2020
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implicationsVictor Desmond Mandel, Matelda Medri, Ausilia Maria Manganoni, et al.
American Journal of Clinical Dermatology|March 14, 2025
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 YearsRaj Chovatiya, Simone Ribero, Andreas Wollenberg, et al.
Pageof 27